{
 "context": "The following article called 'US stocks end sharply lower; S&P 500 -2.57%' was published on 2015-09-28. The body of the article is as follows:\n    \nView Photo \n\nUS stocks fell sharply Monday, joining European equities in retreat after poor Chinese industrial data deepened worries about the world's second-biggest economy. \nThe Dow Jones Industrial Average fell 312.78 points (1.92 percent) to 16,001.89. \nThe broad-based S&P 500 lost 49.57 (2.57 percent) at 1,881.77, while the tech-rich Nasdaq Composite Index tumbled 142.53 (3.04 percent) to 4,543.97. \nGovernment data showed China's crucial industrial companies saw profits fall 8.8 percent in August from a year ago -- hit by last month's shock yuan devaluation, weak demand and plunging share prices. \nThe weak Chinese data hit prices of key commodities such as oil and copper, as well as shares of petroleum-linked companies ConocoPhillips (NYSE: COP - news ) (-2.8 percent) and Schlumberger (LSE: 0CT7.L - news ) (-4.8 percent) and metals producer Freeport-McMoRan (-9.1 percent). \nArt Hogan, chief market strategist at Wunderlich Securities, said investors are brooding over two key questions with no imminent resolution: when the Chinese economy will bottom out and when the US Federal Reserve will raise interest rates. \nAdding to that are other worries, including potential legislation to rein in pharmaceutical prices and the Volkswagen (Other OTC: VLKAF - news ) emissions scandal. \n\"You have a path of least resistance that is lower until you have some answers to the big questions,\" Hogan said.\n\n    The day before the article was published, the stock price of Akari Therapeutics Plc was 24.510000228881836 and the day after the article was published, the stock price of Akari Therapeutics Plc was ",
 "expected": "23.09000015258789",
 "date": "2015-09-28",
 "ticker": "AKTX",
 "company": "Akari Therapeutics Plc"
}